LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

US: Building a Resilient Biomass Supply – A plan to Enable the Bioeconomy in America

21/03/2024

POLICY DOCUMENT

USA, March 2024 - The Plan was developed following the EO on Advancing Biotechnology and Biomanufacturing and built on the basis that biomass is the foundation to the US bioeconomy. 

"The resulting Plan to Enable the Bioeconomy in America: Building a Resilient Biomass Supply focuses on systems of production of biomass as raw material and its pre-processing into feedstocks for many diverse types of biomanufacturing and biobased products in the U.S. bioeconomy. Some of these systems are well-established and primed for expansion, while others are newly emerging. Thus, the plan calls for three broad areas of activity: (1) research, development, and demonstration for innovation in newly emerging biomass supply systems; (2) capacity building to expand existing biomass supply systems; and (3) market development and assessment to match biomass supply to demand for the biobased products."

Source: US Department of Agriculture (USDA).

US: Building a Resilient Biomass Supply - A plan to Enable the Bioeconomy in America


Download

Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

30/05/2025

Open Letter of Business and Agri-Food Industry stakeholders on the need for a high-performing EFSA to boost the competitiveness of the EU agri-food sector


Read more
22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
19/03/2025

Measuring the Economic Footprint of the Biotechnology Industry in the European Union


Read more

Important links

  • EuropaBio Position on the EU Biotech Act: Prosperity, resilience and leadership for the European Union
  • The EU economic and scientific future starts with the EU Biotech Act

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.